Search
Close this search box.

Nanowires engineer naive T cells for immunotherapy – Nature Nanotechnology

Competing interests

L.G. has consulting agreements with Lyell Immunopharma, is on the scientific advisory boards of Poseida Therapeutics and Kiromic, and is a stockholder of Poseida Therapeutics. D.S.-L. declares no competing interests.